Cevimeline and Eslicarbazepine Acetate
Determining the interaction of Cevimeline and Eslicarbazepine Acetate and the possibility of their joint administration.
In the database of official manuals used in the service creation an interaction registered by statistical results of studies was found, which can either lead to negative consequences for the patient health or strengthen a mutual positive effect. A doctor should be consulted to address the issue of joint drug administration.
Consumer:Consumer information for this minor interaction is not currently available. Some minor drug interactions may not be clinically relevant in all patients. Minor drug interactions do not usually cause harm or require a change in therapy. However, your healthcare provider can determine if adjustments to your medications are needed.
Professional:Coadministration with inducers of CYP450 3A4 may theoretically decrease the plasma concentrations of cevimeline, which is a substrate of the isoenzyme. However, the clinical relevance has not been established, since cevimeline is also metabolized by CYP450 2D6, which is not inducible to any significant extent.
- "Product Information. Evoxac (cevimeline)" Daiichi Pharmaceuticals, Fort lee, NJ.
Generic Name: eslicarbazepine
Brand name: Aptiom
Synonyms: Eslicarbazepine
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Cevimeline-Esmolol
- Cevimeline-Esmolol HCl
- Cevimeline-Esmolol Hydrochloride
- Cevimeline-Esmolol Injection
- Cevimeline-Esmolol Intravenous
- Cevimeline-Esomep-EZS
- Eslicarbazepine Acetate-Cevimeline Hydrochloride
- Eslicarbazepine Acetate-Chamomile
- Eslicarbazepine Acetate-Chantix
- Eslicarbazepine Acetate-Chantix Continuing Month Pak
- Eslicarbazepine Acetate-Chantix Start Month Pak
- Eslicarbazepine Acetate-Chantix Starter Pack